Tag: NMITLI

CSIR through its NMITLI program approves a multi institutional project to develop human monoclonal antibodies (hmAbs) that can neutralize SARS-CoV-2 in patients. The project will be implemented by National Centre for Cell Science (NCCS), IIT-Indore and PredOmix Technologies with Bharat Biotech International, as the commercialization partner...........................